Senior Research Scientist
Novartis
Basel, Basel-Stadt, Switzerland
I received my first degree from Edinburgh University, then I moved to the University of Bristol, England, to gain a Ph.D. with Prof. Steve Halford, FRS. Following that I obtained a NATO post-doctoral award to study at Yale University with Nigel Grindley. I then joined Procter & Gamble, and in 1999, I joined the high throughput screening group of Pharmacia in Kalamazoo. In 2003, I left Pharmacia to join the Lead Discovery Group of Novartis in Cambridge, MA., and in 2005 transferred to the Cell Based Screening group in Basel, Switzerland. At the end of 2009 I had the opportunity to set up a high throughput biology laboratory supporting target discovery projects. The group has developed from screening predominantly siRNAs and cDNAs to include pooled CRISPR approaches.
Disclosure information not submitted.
Phenotypic Drug Discovery Topical Interest Group
Wednesday, May 29, 2024
10:00 – 10:45 CEST